Company Monitoring Page for Biogen

latest headlines for company on cafepharma

Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid?
Xconomy
Wed, 06/21/17 - 09:46 am
Tags:
Alzheimer's disease, anti-amyloid, solanezumab, Eli Lilly, Biogen, aducanumab, RVT-101
5 Most Profitable Big Pharma Stocks on the Market Right Now
Motley Fool
Wed, 06/21/17 - 09:37 am
Tags:
Big Pharma, Gilead Sciences, Amgen, Novartis, Biogen, Bristol-Myers Squibb
Celgene touts ozanimod MS data, but disability benefit weak over rival med
Fierce Biotech
Mon, 05/22/17 - 09:41 am
Tags:
Celgene, ozanimod, MS, multiple sclerosis, Biogen, Avonex
Focused on new deals, Biogen bags a PhIII drug for ischemic stroke with $120M upfront
Endpoints
Mon, 05/15/17 - 09:03 am
Tags:
Biogen, ischemic stroke, CIRARA, Remedy Pharmaceuticals
These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016
Motley Fool
Sat, 04/29/17 - 10:12 am
Tags:
earnings, drug pricing, Biogen, Eli Lilly, AbbVie, Allergan, Merck, Pfizer, Amgen
Biogen’s Spinraza Witnessed Robust Patient Demand in 1Q17
Market Realist
Fri, 04/28/17 - 11:45 am
Tags:
Biogen, Spinraza, patients, SMA, spinal muscular atrophy
Biogen Reports Strong Revenue Growth in 1Q17
Market Realist
Thu, 04/27/17 - 09:38 am
Tags:
Biogen, earnings
Scangos left Biogen in style, taking a final $17.7M compensation package for one last, disappointing year
Endpoints
Thu, 04/27/17 - 09:13 am
Tags:
George Scangos, Biogen, executive pay
​Hyde Park boy with rare disease wins appeal, will receive Biogen drug
Bizjournals.com
Wed, 04/26/17 - 09:35 pm
Tags:
Biogen, Spinraza, SMA, spinal muscular atrophy
Biogen touts stronger-than-expected rollout for Spinraza
BioPharma Dive
Wed, 04/26/17 - 10:58 am
Tags:
Biogen, Spinraza, drug launches, SMA, spinal muscular atrophy
​Biogen shares jump as launch of new drug beats expectations
Bizjournals.com
Tue, 04/25/17 - 11:29 am
Tags:
Biogen, Spinraza, earnings
Biogen looks to M&A to overcome competition to its MS franchise
Fierce Pharma
Mon, 04/24/17 - 10:05 pm
Tags:
Biogen, M&A, MS
Facing a payer backlash over sticker shock, Biogen fields positive data on Spinraza for children 2-12
Endpoints
Mon, 04/24/17 - 10:09 am
Tags:
Biogen, Spinraza, payers
Biogen Says It's Back and Ready for ‘Highly Active’ Dealmaking
Yahoo/Bloomberg
Sun, 04/23/17 - 09:54 am
Tags:
Biogen, M&A, Bristol-Myers Squibb
Biogen Snaps Up A 'Rare Find' From BMS: Instinet
Barron's
Sat, 04/15/17 - 09:25 am
Tags:
Biogen, Bristol-Myers Squibb, BMS-986168, progressive supranuclear palsy
Bristol-Myers to license two drugs to Biogen, Roche
Yahoo/Reuters
Thu, 04/13/17 - 11:52 am
Tags:
Bristol-Myers Squibb, Biogen, Roche, BMS-986168, BMS-986089
In Biotech, Biogen, Gilead, Alexion Earnings Will Steal The Spotlight
Barron's
Wed, 04/12/17 - 11:03 am
Tags:
biotech, earnings, Biogen, Gilead Sciences, Alexion
Why Roche's New Drug Is Bad News For Biogen
Barron's
Sun, 04/9/17 - 12:20 pm
Tags:
Roche, Biogen, Ocrevus, multiple sclerosis, MS, Tysabri, Tecfidera
Earnings Preview: Biotechnology Looks Healthy
Barron's
Sat, 04/8/17 - 12:52 pm
Tags:
earnings, biotech, Amgen, Celgene, Vertex Pharmaceutials, Biogen, Akorn
Forward Pharma Intends to Appeal Decision in Patent Interference Proceeding with Biogen Inc.
Yahoo
Sat, 04/1/17 - 08:07 am
Tags:
Biogen, Tecfidera, patents, Forward Pharma, MS, multiple sclerosis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.